Cost-Effectiveness of Roflumilast As Add-On To Triple Inhaled Therapy Vs Triple Inhaled Therapy In Patients with Severe And Very Severe COPD Associated with Chronic Bronchitis In Sweden
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1201
https://www.valueinhealthjournal.com/article/S1098-3015(16)32567-0/fulltext
Title :
Cost-Effectiveness of Roflumilast As Add-On To Triple Inhaled Therapy Vs Triple Inhaled Therapy In Patients with Severe And Very Severe COPD Associated with Chronic Bronchitis In Sweden
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32567-0&doi=10.1016/j.jval.2016.09.1201
First page :
A554
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1127